United States Biopharmaceutical Third Party Logistics Markets, 2021-2028


DUBLIN, January 7, 2022 / PRNewswire / – The “US Biopharmaceutical Third Party Logistics Market Size, Share and Trend Analysis Report by Product Type (Specialty Drugs, Generics), by Supply Chain ( non-refrigeration, cold chain), by type of service and segment forecast, The 2021 – 2028 report “has been added to ResearchAndMarkets.com offer.

Research and Markets logo

The size of the US biopharmaceutical third-party logistics market is expected to reach $ 62.3 billion by 2028, at a CAGR of 7.1%

The growing demand for new biologics and the need to manage them is driving the growth of the market. In addition, the growing demand for temperature controlled logistics services to transport the biologics to various regions and the growing distribution networks of the biopharmaceutical companies to improve their sales are factors driving the growth of the market.

The COVID-19 pandemic has had a major impact on global logistics to some extent due to declining air cargo capacity and reduced manpower in warehouses and airports. Decisions by local authorities to shut down logistics infrastructure, impose movement restrictions or put in place additional requirements to suppress transmission of the virus have also had an impact on logistics services. This considerably hampered many procurement operations.

The future looks lucrative for the market with the withdrawal of government regulations related to transport and shelter-in-place mandates. A sudden increase in demand for cold chain logistics was observed during the pandemic. Growth in the manufacture and distribution of the COVID-19 vaccine is expected throughout 2021.

For example, in March 2021FedEx Express has started shipping COVID19 vaccine for McKesson Corp. in centers across the United States The company has already shipped millions of COVID-19 vaccines since mid-December 2020.

Highlights of the U.S. 3PL Biopharmaceuticals Market Report

  • Non-cold chain logistics held the largest market share of 80.8% in 2020 due to the sale of a large number of drugs that did not require temperature control

  • The cold chain logistics segment is expected to experience the fastest CAGR of 10.1% during the forecast period owing to the demand for biologics, such as cell therapies, vaccines and kits. test.

  • The increasing demand for the COVID-19 vaccine is a major factor contributing to the growth of the market. In addition, the growing trend of outsourcing logistics services is fueling the growth

  • Warehousing and warehousing segment held largest revenue share of 43.6% in 2020 due to growing demand for storage

  • Specialty Drugs Segment Dominated the Market in 2020 Due to Rapid Growth of Specialty Drugs

Main topics covered:

Chapter 1. Methodology and scope
1.1 Market segmentation and scope
1.2 Research methodology
1.3 Information acquisition
1.4 Information or data analysis
1.5 Market formulation and validation
1.6 Model details

Chapter 2. Executive summary
2.1 Market outlook

Chapter 3. Market definition
3.1 By supply chain
3.2 By type of service
3.3 By product type

Chapter 4. United States Biopharmaceutical Third Party Logistics Market: Variables, Trends and Scope
4.1 Market Segmentation and Scope
4.2 Analysis of market drivers
4.2.1 Technological advances in logistics
4.2.2 Growing Applications of Reverse Logistics in the Biopharmaceutical Industry
4.2.3 Growing demand for cold chain logistics
4.3 Analysis of market restrictions
4.3.1 Compliance issues when outsourcing
4.4 Mapping of penetration and growth prospects
4.5 Porter’s five forces analysis
4.6 PESTEL analysis

Chapter 5. Qualitative information for Hub services, co-payment and membership
5.1 Hub services
5.2 Co-pay
5.3 Membership

Chapter 6. United States Biopharmaceutical Third-Party Logistics Market: Supply Chain Segment Analysis
6.1 United States Biopharmaceutical Third Party Logistics Market: Market Share Analysis, 2020 and 2028
6.2 Cold chain logistics
6.3 Logistics outside the cold chain

Chapter 7. United States Biopharmaceutical Third Party Logistics Market: Service Type Segment Analysis
7.1 United States Biopharmaceutical Third Party Logistics Market: Market Share Analysis, 2020 and 2028
7.2 Transport
7.2.1 Transport Market, 2016-2028 (USD Billion)
7.2.2 Air freight
7.2.3 Sea freight
7.2.4 Land transport
7.3 Warehousing and storage

Chapter 8. United States Biopharmaceutical Third Party Logistics Market: Product Type Segment Analysis
8.1 United States Biopharmaceutical Third Party Logistics Market: Market Share Analysis, 2020 and 2028
8.2 Specialty drugs
8.3 Generics
8.4 Plasma-derived products

Chapter 9. Company Profiles

  • Agility

  • Amerisourcebergen Company

  • Db schenker

  • DHL International GmbH

  • Fedex

  • Kerry Logistics Network Limited

  • Kuehne + Nagel

  • SF Express

  • United Parcel Service Of America, Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/8ilmqx

Media contact:

Research and markets
Laura Woodsenior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716

Cision

Cision

View original content: https://www.prnewswire.com/news-releases/united-states-biopharmaceutical-third-party-logistics-markets-2021-2028—growing-applications-of-reverse-logistics-in – industry-biopharmaceutical-301456227.html

SOURCE Research and Markets

Previous Profile: Bradley Hagen, Bartender at Swordfish
Next UPDATE: Singapore-Malaysia VTLs are a comfort to families looking for reunion, but Omicron has other plans in store